Results 91 to 100 of about 491,626 (323)

A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children

Pediatric Blood &Cancer, EarlyView.
ABSTRACT This UK national audit aimed to assess adherence to evidence‐based chemotherapy‐induced nausea and vomiting (CINV) guidelines for children with cancer, which emphasise treatment emetogenicity assessment, symptom monitoring and appropriate antiemetic use.
Eloise Neumann, Thomas J. Jackson, Jessica E. Morgan, Robert Phillips, Jessica Bate, the CCLG Supportive Care Group   +5 more
wiley   +1 more source

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine

Frontiers in Oncology
Secondary acute lymphoblastic leukemia (s-ALL) refers to acute lymphoblastic leukemia that occurs after a previous malignant tumor, including therapy-related acute lymphoblastic leukemia (t-ALL) and prior malignant tumor acute lymphoblastic leukemia (pm ...
Mengci Hu, Wenzhe Li, Pan Li, Jie Tan, Ya Wang, Ya Wang   +5 more
doaj   +1 more source

Development and validation of a nutrition risk screening for patients with childhood cancer in Brazil (NUTRICCAN)

Nutrition in Clinical Practice, EarlyView.
Abstract Background Diagnosing malnutrition in patients with pediatric cancer is challenging because tumor masses can interfere with anthropometric measurements. STRONGkids considers cancer a general risk factor, whereas Screening Tool for Childhood Cancer (SCAN) classifies patients as at risk or not, potentially missing those who need nutrition ...
Cristiane Ferreira Marçon, Carolina Araújo dos Santos, Fernanda Luisa Ceragioli Oliveira   +2 more
wiley   +1 more source

B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Enhancing Circle‐of‐Care Communication in Pediatric Cancer Through Digital Health Technologies: A Scoping Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Effective communication in pediatric cancer care is crucial for informed decision‐making among patients, caregivers, and healthcare providers. This scoping review assesses evidence on digital tools designed to enhance circle‐of‐care communication for pediatric cancer patients and families.
Aljeena Rahat Qureshi, Kaitlyn Flegg, Ashar Siddiqui, Brendan K. Tao, Brenda Gallie   +4 more
wiley   +1 more source

Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma

Cytometry. Part B, Clinical cytometry, 2019
In this review, we discuss applications of flow cytometric immunophenotyping (FCI) in the diagnostic evaluation and posttreatment monitoring of B and T lymphoblastic leukemia/lymphoma.
Joseph A. DiGiuseppe, B. Wood
semanticscholar   +1 more source

Patient and Family Demographics in the Momcology Pediatric Cancer Patient Advocacy Organization

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Momcology is a US‐based patient advocacy organization that provides support for families of children with cancer. This study describes Momcology for researchers by detailing the demographic, clinical, and socioeconomic (socioeconomic status [SES]) data within its registry and comparing it to the National Surveillance, Epidemiology ...
Ryan Salama, Alexis Shuck, Zhanni Lu, Kimberly Buff, Michelle A. Roesler, Catherine Paciente, Logan G. Spector   +6 more
wiley   +1 more source

[Allogeneic hematopoietic stem cell transplantation combined with CD7 CAR-T for the treatment of T lymphoblastic lymphoma: a case report and literature review]. [PDF]

, 2023
Xueting Wang, Yongjun Zhou, J L Zhang, H Y Zhou, Qi Zhang, Qingqing Sun, Huanhuan Li, Linyan Xu, Shuna Yao, Zhihua Yao, Dongmei Yan, Kailin Xu, Wei Sang   +12 more
openalex   +1 more source

International Consensus Classification of acute lymphoblastic leukemia/lymphoma

Virchows Archiv, 2022
A. Duffield, C. Mullighan, M. Borowitz
semanticscholar   +1 more source

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Blood Cancer Journal, 2015
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic ...
C. Papayannidis, D. DeAngelo, W. Stock, B. Huang, M. N. Shaik, R. Cesari, Xianxian Zheng, Jennifer M. Reynolds, P. English, M. Ozeck, J. Aster, F. Kuo, Donghui Huang, Paul D. Lira, K. Mclachlan, K. Kern, G. Garcia-Manero, Giovanni Martinelli   +17 more
semanticscholar   +1 more source